World's Best Scientists 2026 revealed!
Philippe Gaulard

Philippe Gaulard

D-Index & Metrics

Medicine

D-Index
120
Citations
54475
World Ranking
3744
National Ranking
106

Philippe Gaulard publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philippe Gaulard sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 570 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philippe Gaulard D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Gaulard sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 120 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philippe Gaulard is affiliated with Université Paris Cité in France. Their research primarily focuses on Medicine, with significant contributions in subfields such as Pathology and Forensic Medicine, Oncology, and Immunology. Additional areas of study include Dermatology and Molecular Biology.

Their academic output covers numerous topics related to hematologic malignancies and immunology, with a particular emphasis on lymphoma and related disorders. Main topics of their work include:

  • Lymphoma Diagnosis and Treatment
  • T-cell and Retrovirus Studies
  • Viral-associated cancers and disorders
  • CAR-T cell therapy research
  • Cutaneous lymphoproliferative disorders research
  • Immune Cell Function and Interaction
  • Chronic Lymphocytic Leukemia Research

Gaulard has published extensively in several scientific journals. Their most frequent publication venues are:

  • Blood
  • Hematological Oncology
  • HemaSphere
  • Journal of Clinical Oncology
  • Blood Advances

Among their recent papers are:

  • "Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)", 2021, Journal of Clinical Oncology
  • "High total metabolic tumor volume at baseline predicts survival independent of response to therapy", 2020, Blood
  • "Genomic profiling for clinical decision making in lymphoid neoplasms", 2022, Blood
  • "Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma", 2020, Journal of Clinical Oncology
  • "Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial", 2020, Leukemia

Gaulard has collaborated frequently with a group of co-authors, including Laurence de Leval, François Lemonnier, Emmanuel Bachy, Olivier Tournilhac, and Gandhi Damaj.

Best Publications

  • CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  • Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    P Feugier;A. Van Hoof;C. Sebban;P. Solal-Celigny

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

    S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks

  • Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

    Nicolas Mounier;Josette Briere;Christian Gisselbrecht;Jean-Francois Emile

  • Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

    Christian Gisselbrecht;Philippe Gaulard;Eric Lepage;Bertrand Coiffier

  • The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

    Laurence de Leval;David S. Rickman;Caroline Thielen;Aurélien de Reynies

  • [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

    Corinne Haioun;Emmanuel Itti;Alain Rahmouni;Pauline Brice

  • Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

    Corinne Haioun;Eric Lepage;Christian Gisselbrecht;Gilles Salles

  • Prognostic significance of survivin expression in diffuse large B-cell lymphomas

    Colette Adida;Corinne Haioun;Philippe Gaulard;Eric Lepage

  • Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    O Hermine;C Haioun;E Lepage;MF d'Agay

  • Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

    Frédéric Peyrade;Fabrice Jardin;Catherine Thieblemont;Antoine Thyss

  • IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

    Rob A. Cairns;Javeed Iqbal;François Lemonnier;Can Kucuk

  • Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma

    Olivier Hermine;Corinne Haioun;Eric Lepage;Marie-Françoise D'Agay

  • Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

    Javeed Iqbal;George Wright;Chao Wang;Andreas Rosenwald

  • Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

    François Lemonnier;François Lemonnier;Lucile Couronné;Marie Parrens;Jean-Philippe Jaïs

  • Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

    Karim Belhadj;Felix Reyes;Jean-Pierre Farcet;Herve Tilly

  • Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus

    Panagiotis Kanavaros;Marie-Claude Lescs;Josette Brière;Marine Divine

  • A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response.

    Rafaèle Tordjman;Yves Lepelletier;Valérie Lemarchandel;Marie Cambot

  • Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

    Can Küçük;Bei Jiang;Xiaozhou Hu;Wenyan Zhang

Frequent Co-Authors

Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Hervé Tilly
Hervé Tilly University of Rouen
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
François A. Lemonnier
François A. Lemonnier Université Paris Cité
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Jean-Pierre Farcet
Jean-Pierre Farcet Paris-Est Créteil University
Thierry Jo Molina
Thierry Jo Molina Université Paris Cité
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in exploring healthcare careers beyond traditional medical school, there are affordable online degree options worth considering. Careers in medical billing and coding, nursing, and advanced nursing practice offer flexible online pathways into the healthcare industry.

For those drawn to administrative and support roles, understanding medical billing and coding cost can help you choose a program that fits your budget. These programs are often shorter and lead directly to in-demand positions within hospitals and clinics.

Prospective nurses can benefit from researching what is the cheapest online college for nursing?. Affordable accredited programs make it possible to earn your degree without significant debt, enabling you to start a nursing career sooner.

If advancing in the nursing field is your goal, consider the cheapest fnp programs to become a Family Nurse Practitioner. Alternatively, a Doctor of Nursing Practice degree can be pursued for less by reviewing cheapest online dnp programs.

These online options provide flexible, affordable entry points to high-demand healthcare roles, letting you shape a rewarding career while managing costs.

Best Scientists Citing Philippe Gaulard

Trending Scientists

Recently Published Articles